Viewing StudyNCT06011772



Ignite Creation Date: 2024-05-06 @ 7:27 PM
Last Modification Date: 2024-10-26 @ 3:06 PM
Study NCT ID: NCT06011772
Status: RECRUITING
Last Update Posted: 2024-05-03
First Post: 2023-08-21

Brief Title: EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Sponsor: Roswell Park Cancer Institute
Organization: Roswell Park Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Colo-rectal Cancer
Keywords: